Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.23.1
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Revenues $ 28,450,298 $ 22,438,538
Depreciation and amortization 2,342,544 1,629,176
Segment operating income (678,237) (176,426)
Other income (expense), net 3,821,162 (16,147)
Income (loss) before income tax benefit 3,142,925 (192,573)
Operating Segments    
Segment Reporting Information [Line Items]    
Segment operating income 4,094,718 3,965,174
Unallocated corporate    
Segment Reporting Information [Line Items]    
Segment operating income (4,772,955) (4,141,600)
Corporate clinics    
Segment Reporting Information [Line Items]    
Revenues 17,127,957 12,606,999
Corporate clinics | Operating Segments    
Segment Reporting Information [Line Items]    
Depreciation and amortization 2,054,580 1,376,196
Segment operating income (549,542) (438,064)
Franchise operations    
Segment Reporting Information [Line Items]    
Revenues 11,322,341 9,831,539
Franchise operations | Operating Segments    
Segment Reporting Information [Line Items]    
Depreciation and amortization 198,974 173,487
Segment operating income 4,644,260 4,403,238
Corporate administration    
Segment Reporting Information [Line Items]    
Depreciation and amortization $ 88,990 $ 79,493